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Clinical background
The immunosuppressive drug FK506 reveals an anti-
malarial activity. The mechanism of the drug action
involves the molecular interaction with target proteins
PfFKBP35 and PvFKBP35 from P. falciparum and
P. vivax, respectively. Interestingly, non-immunosup-
pressive FK506 analogues also show antimalarial activ-
ities. This prompted us to attempt to develop potential
small molecule antagonists that specifically target the
parasite enzymes devoid of immunosuppressive activ-
ity. To this end, we have determined the three-dimen-
sional structures of the FK506 binding domain (FKBD)
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Figure 1 FK506 in complex with PvFKBD and ternary complex of FK506/PfFKBD/Calcineurin. (A) The electron density map of FK506 at the ligand
binding site in PvFKBD. The residues near the FK506 are labeled and displayed as stick model in element colors. (B) Electrostatic surface
representation of the residues near the FK506 binding sites in PvFKBD. Positive and negative charges are in blue and red, respectively. (C)
Ternary complex model of FK506-bound PfFKBD and calcineurin. PfFKBD (yellow) was overlaid onto FKBP12 (pale cyan) of the FKBP12-FK506-
calcineurin ternary complex in order to construct the ternary complex. FK506 is shown in sticks and calcineurin is shown in blue and cyan with
its subunits A and B, respectively.
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of P. falciparum and P. vivax in unligand form and in
complex with FK506.The structural studies reveal that
the Plasmodium FKBPs have similar structural folds
like the canonical FKBP folds (Figure 1 overleaf), pro-
viding mechanistic insights into PfFKBP35 and
PvFKBP35 with possible routes for rational antimalarial
drug design targeting the Plasmodium FKBPs.
Conclusion
Our structure-guided drug screening efforts resulted in
an identification of novel adamantanyl-based-antimalar-
ial compound named Supradamal (SRA). SRA exhibits a
nanomolar inhibitory activity in both peptidylprolyl
cis-trans isomerase (PPIase) assay and growth of P. falci-
parum cultured in human erythrocytes. In particular,
SRA appears to inhibit the trophozoite development.
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